[
  {
    "date": "2022-12-31",
    "symbol": "PROC",
    "period": "FY",
    "revenue": 19844000,
    "costofsales": 4504000,
    "grossprofit": 239569000,
    "salesandmarketingexpense": 93566000,
    "generalandadministrativeexpense": 105911000,
    "financeincomeexpensesnet": -37917000,
    "otherexpensebynature": 494000,
    "profitlossbeforetax": 52710000,
    "incometaxexpensecontinuingoperations": 10170000,
    "profitloss": -2040000,
    "profitlossattributabletoownersofparent": 42540000,
    "basicearningslosspershare": 0.42,
    "othercomprehensiveincomebeforetaxgainslossesonremeasurementsofdefinedbenefitplans": -222000,
    "incometaxrelatingtocomponentsofothercomprehensiveincomethatwillnotbereclassifiedtoprofitorloss": -107000,
    "othercomprehensiveincomethatwillnotbereclassifiedtoprofitorlossnetoftax": -115000,
    "gainslossesonexchangedifferencesontranslationnetoftax": -5966000,
    "othercomprehensiveincomebeforetax": -6081000,
    "comprehensiveincome": 36459000,
    "comprehensiveincomeattributabletoownersofparent": -2040000,
    "comprehensiveincomeattributabletononcontrollinginterests": 3000,
    "dilutedearningslosspershare": 0.5,
    "propertyplantandequipment": 4019000,
    "rightofuseassets": 1263000,
    "goodwill": 5791000,
    "intangibleassetsotherthangoodwill": 18908000,
    "investmentsinsubsidiariesjointventuresandassociates": 1505000,
    "othernoncurrentfinancialassets": 210000,
    "deferredtaxassets": 6974000,
    "othernoncurrentassets": 3078000,
    "noncurrentassets": 2970000,
    "cashandcashequivalents": 43003000,
    "tradeandothercurrentreceivables": 129602000,
    "inventories": 3930000,
    "tradeandothercurrentreceivablesduefromrelatedparties": 2474000,
    "currenttaxassets": 21187000,
    "othercurrentassets": 4344000,
    "currentassets": 10107000,
    "assets": 460187000,
    "issuedcapital": 1011000,
    "sharepremium": 377677000,
    "otherreserves": 45743000,
    "retainedearnings": -391513000,
    "accumulatedothercomprehensiveincome": -33859000,
    "equityattributabletoownersofparent": -941000,
    "noncontrollinginterests": -937000,
    "equity": 3789000,
    "longtermborrowings": 28410000,
    "noncurrentwarrantliability": 10916000,
    "sharesheldescrow": 40064000,
    "deferredtaxliabilities": 7821000,
    "othernoncurrentliabilities": 6480000,
    "noncurrentliabilities": 866000,
    "shorttermborrowings": 257525000,
    "tradeandothercurrentpayables": 90187000,
    "tradeandothercurrentpayablestorelatedparties": 2914000,
    "currenttaxliabilities": 6133000,
    "currentprovisions": 138000,
    "othercurrentliabilities": 11477000,
    "currentliabilities": 8422000,
    "equityandliabilities": 460187000,
    "profitlossfortheyear": 42540000,
    "increasedecreasethroughsharebasedpaymenttransactions": -2994000,
    "increasedecreasethroughtransfersandotherchangesequity": -6081000,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": -5656000,
    "adjustmentsfordepreciationofrightofuseassets": 6255000,
    "adjustmentsforamortizationofintangibles": 4933000,
    "adjustmentsforincometaxexpense": 10170000,
    "financeexpenses": -37917000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 1652000,
    "adjustementforshareofresultofjointventures": 919000,
    "adjustmentsforimpairmentlossreversalofimpairmentlossrecognisedinprofitorlossinventories": -555000,
    "adjustmentsforgainlossondisposalsintangibles": 203000,
    "adjustmentsforimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 4689000,
    "impairmentlossonrouasset": 356000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 4689000,
    "adjustmentsforimpairmentlossrecognisedinprofitorlossgoodwill": 838000,
    "adjustmentsforinventoryprovision": 5717000,
    "reversedprovisionforbaddebt": -2673000,
    "adjustmentsforprovisions": 43000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": 48307000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -16582000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivablefromrelatedparties": 474000,
    "adjustmentsfordecreaseincreaseininventories": -32690000,
    "adjustmentsforcurrenttaxassets": 895000,
    "adjustmentsfordecreaseincreaseinothercurrentassets": 1500000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 14210000,
    "adjustmentsfordecreaseincreaseinamountsowedtorelatedparties": 1998000,
    "adjustmentsforincreasedecreaseincurrenttaxliabilities": 6643000,
    "adjustmentsforincreasedecreaseinotherliabilities": 10865000,
    "adjusmentsforincreasedecreaseforprovisions": -415000,
    "otherfinancialasset": 46000,
    "adjustmentsfordecreaseincreaseinotherassets": 710000,
    "cashflowsfromusedinoperations": 22675000,
    "interestpaidclassifiedasoperatingactivities": 1261000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 7308000,
    "cashflowsfromusedinoperatingactivities": 14106000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 20612000,
    "proceedsfromsalesofintangibleassetsclassifiedasinvestingactivities": 2686000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 10963000,
    "proceedsfromrelatedparties": 61000,
    "cashflowsfromusedininvestingactivities": -28828000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 134412000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 124202000,
    "cashadvancesandloansfromrelatedparties": 61000,
    "cashrepaymentsofadvancesandloansfromrelatedparties": 7191000,
    "interestpaidclassifiedasfinancingactivities": 10028000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 6679000,
    "cashflowsfromusedinfinancingactivities": -13627000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -28349000,
    "effectofexchangeratechangesoncashandcashequivalents": -760000,
    "noncashfinancingandinvestingactivitiesamount": 50897000,
    "recentaccountingpronouncementsnotyetadoptedtextblock": "Note 6. Recent accounting pronouncements not yet adopted ",
    "disclosureofwarrantliabilityexplanatory": "Note 25. Warrant Liabilities ",
    "disclosureofassetacquisitionexplanatory": "Note 26. Acquisitions ",
    "transactionsinforeigncurrencypolicytextblock": "Transactions in foreign currency",
    "financialliabilitiesandequityinstrumentspolicytextblock": "Financial liabilities and equityinstruments",
    "principlesofconsolidationandequityaccountingpolicytextblock": "Principles of consolidation and equity accounting",
    "disclosureofusefullivesofpropertyplantandequipmentexplanatory": "      Buildings    20 - 40 years      Machinery and equipment    10 - 20 years      Furniture and fixtures    2 - 10 years      Other equipment    2 - 5 years   ",
    "disclosureofusefullivesofintangibleassetsexplanatory": "      Trademarks and sanitary records    3 – 20 years       Licenses, customers and agreements    3 – 10 years      Product development    3 years   ",
    "disclosureofincometaxrecognizedthroughprofitorlossexplanatory": "            For the year ended December 31             2022      2021      2020       Current year      8,407       12,250       7,491       Current tax expense      8,407       12,250       7,491                                      Origination and reversal of temporary differences      1,763       1,455       3,805       Deferred tax (income) expense      1,763       1,455       3,805                                      Total tax expense      10,170       13,705       11,296    ",
    "disclosureoftaxlossesandexcesspresumptiveincomeofthecompanythathavenotbeenusedandonwhichnoactivedeferredtaxhasbeenrecognizedexplanatory": "            As of December 31             2022      2021       Tax Losses not utilized      4,752       3,242       Total      4,752       3,242   ",
    "disclosureofleaseliabilitiesexplanatory": "            2022      2021       Non-current     $25,139      $21,894       Current      9,053       9,853       Total     $34,192      $31,747    ",
    "disclosureofleasesrelatedcostsrecognizedintheconsolidatedstatementofprofitorlossexplanatory": "            For the year ended December 31             2022      2021       Interest on lease liabilities     $1,033      $720       Expense relating to leases of low-value assets      115       123       Expense relating to short-term leases      862       1,217    ",
    "disclosureofcarryingamountofthecompanysinterestinpromedicalsaexplanatory": "      Name of joint venture     Principal activity     Place of incorporation and principal place    of business     Proportion of ownership interest and voting rights held by the Company                         As of December 31, 2022      As of December 31, 2021       Promedical S.A.     Marketing and pharmaceuticals     Santa Cruz de la Sierra, Bolivia      50%      50%   ",
    "disclosureoffinancialinformationofjointventureexplanatory": "            As of December 31             2022      2021       Current assets     $10,107      $10,324       Non-current assets      2,970       3,136       Current liabilities      8,422       6,231       Non-current liabilities      866       795       Equity      3,789       6,434       Revenue      19,844       23,704       (Loss)/income for the year      (2,040)      1,423       Total comprehensive (loss)/income      (2,040)      1,423    ",
    "disclosureofinventoryexplanatory": "            2022      2021       Raw materials and supplies     $42,701      $38,024       Products in process      7,412       6,240       Finished products and merchandise      41,492       31,791       Inventory in transit      11,531       9,645       Subtotal      103,136       85,700       Less: Provision      (6,303)      (6,270)      Total     $96,833      $79,430    ",
    "disclosureoftradeandotherreceivableexplanatory": "            As of December 31             2022      2021       Trade receivables, net of discounts 1     $126,456      $111,071       Other receivables      15,211       16,408       Impairment of trade and other receivables 2      (12,065)      (10,030)      Trade receivables, net of discounts and impairment     $129,602      $117,449    ",
    "disclosureofnetdeferredtaxassets": "            As of December 31             2022      2021       Deferred Tax Asset     $6,974      $7,067       Deferred Tax Liability      (7,821)      (6,070)      Net Deferred Tax Asset (Liability)     $(847)     $997    ",
    "disclosureofreconciliationofchangesindeferredtaxliabilityassetexplanatory": "            2022      2021      2020       Balance as of January 1     $997      $2,879      $8,556       Recognized in Profit or Loss      (1,763)      (1,455)      (3,805)      Recognized in Other Comprehensive Income 1      107       (58)      16       Others 2      (188)      (369)      (1,888)      Balance as of December 31     $(847)     $997      $2,879    ",
    "disclosureoftradeandotherpayableexplanatory": "            As of December 31             2022      2021       Trade payables     $81,477      $70,167                              Other payables                      Trade current accounts      808       3,259       Interest payable      3,307       1,870       Withholdings and payroll contributions      2,512       6,619       Others      2,082       3,466       Total other payables      8,709       15,214       Total accounts payable     $90,187      $85,381   ",
    "disclosureofcurrentprovisionsexplanatory": "            2022      2021       Provisions and contingencies                    Balance as of January 1     $501      $1,829       Effect of changes in foreign exchange rates      9       (209)      Provisions made      43       —       Provisions used      (415)      (1,119)      Balance as of December 31     $138      $501    ",
    "disclosureaggregatesubscriptionpriceexplanatory": "            Number of shares      Aggregate value       Public shares      5,895,494       58,955       Founder shares      4,300,000       43,000       PIPE Shares      10,000,000       100,000              20,195,494       201,955    ",
    "disclosureofcostbasisoftheexchangeexplanatory": "            Share premium       SPAC net assets      131,086       Transactions costs      (30,063)      IFRS 2 Share-based payment expense      73,917       Share Capital issued      (202)             174,738    ",
    "disclosuresofwarrantliabilityexplanatory": "            As of December 31             2022      2021       Public warrants     $9,200      $16,000       Private warrants1      1,716       7,112             $10,916      $23,112    ",
    "disclosureofpublicwarrantliabilityexplanatory": "            2022      2021       As of January 1     $16,000      $—       Acquired public warrants      —       21,600       Fair value remeasurement      (6,800)      (5,600)      As of December 31     $9,200      $16,000    ",
    "disclosureofprivatewarrantliabilityexplanatory": "            2022      2021       As of January 1     $7,112      $—       Acquired private warrants      —       7,363       Fair value remeasurement      (5,396)      (251)      As of December 31     $1,716      $7,112    ",
    "disclosureofreversereorganizationtransactionexplanatory": "      (Amount in thousands)     2021       Cash held in trust     $138,046       Cash and cash equivalents      100,000       Redemption liability      (77,997)      Warrants liability      (28,963)      Total SPAC identifiable net assets at fair value     $131,086    ",
    "disclosureofthefinalallocationofthepurchasepricebasedontheestimatedfairvaluesoftheassetsacquiredandliabilitiesassumedatthedateofacquisitionexplanatory": "      (Amount in thousands)     2021       Property, Plant and Equipment     $1,487       Inventories      133       Other receivables      193       Right of Use Assets      4,533       Lease Liabilities      (4,533)      Total     $1,813   ",
    "disclosureofcarryingamountsofthegroupsforeigncurrencydenominatedmonetaryassetsandmonetaryliabilitiesexplanatory": "            Assets      Liabilities             2022      2021      2022      2021       COP      105,048       124,545       (79,476)      (99,371)      Reales      25,479       7,002       (9,962)      (9,125)      Quetzales      —       1,946       —       (4,115)      Soles      14,667       7,024       (8,905)      —       Dominican Peso      1,064       809       (3,563)      (2,869)      Colones      1,346       1,270       (2,814)      (2,371)   ",
    "disclosureofsensitivityanalyzeshavebeendeterminedbasedonexposureoffinancialliabilitiestothehighlightedvariableinterestratesexplanatory": "            2022      2021             Carrying amount      +1%      -1%      Carrying amount      +1%      -1%       DTF/IBR      79,345       80,138       78,551       67,970       68,650       67,290       SOFR      23,454       23,688       23,219       19,451       19,646       19,256       Total      102,799       103,827       101,771       87,421       88,296       86,546    ",
    "disclosureofindebtednessindexexplanatory": "            2022      2021       Total assets 1      460,187       462,135       Total liabilities 2      462,065       500,475       Liabilities to assets ratio      1.00       1.08    ",
    "disclosureofnetamountsowedtorelatedpartiesexplanatory": "            As of December 31             2022      2021       Trade and other receivables by related parties     $14,028       12,491       Loans owed by related parties      215       276       Less: provisions      (11,769)      (11,620)      Amounts owed by related parties, net     $2,474      $1,147    ",
    "disclosureofloanstoandfromrelatedpartiesexplanatory": "      Loans to related parties     2022      2021      2020       Balance as of January 1     $276      $304      $499       Loans advanced      —       —       —       Loan repayments received      (61)      (28)      (195)      Balance as of December 31     $215      $276      $304    ",
    "disclosureoftotalmanagementcompensationincludedintheconsolidatedstatementofprofitorlossexplanatory": "            For the year ended December 31             2022      20211      20201       Short-term employee benefits     $2,415      $2,202      $1,972       Consulting fees      3,357       2,730       1,971       Total     $5,772      $4,932      $3,943    ",
    "principalplaceofbusinessandcountryofincorporationandofsubsidiary": "Colombia",
    "proportionofownershipinterestsheldbythegroup": 1,
    "descriptionofprincipalactivities": "Diabetes solutions and chronic disease management tool.",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": 5,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": 3,
    "operations": "Diabetes solutions and chronic disease management tool",
    "segmentrevenue": 597221000,
    "intrasegmentrevenue": 187301000,
    "revenuefromcontractswithcustomers": 10193000,
    "goodstransferredatapointintime": 402822000,
    "servicestransferredovertime": 7098000,
    "grossprofitnetofsalesandmarketingexpenses": 146003000,
    "financeincomecost": 37917000,
    "miscellaneousotheroperatingexpense": 25299000,
    "bankandsimilarcharges": 781000,
    "feeandcommissionexpense": 8498000,
    "otherfinancialexpenses": 1033000,
    "netfairvaluegainofwarrantliabilities": 12196000,
    "netfairvaluegainofsharesheldinescrow": 61795000,
    "interestexpense": 25762000,
    "totalincomeexpense": 37917000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 15984000,
    "economicemergencycontributionexpenses": 1301000,
    "finessurchargespenaltiesandtaxesassumed": 1119000,
    "donationsandsubsidiesexpense": 814000,
    "listingexpense": 73917000,
    "impairmentlossonfinancialassets": 6018000,
    "otheroperatingincomeexpense": 63000,
    "currenttaxexpenseincome": 8407000,
    "currenttaxexpenseincomeandadjustmentsforcurrenttaxofpriorperiods": 8407000,
    "deferredtaxexpenseincomerelatingtooriginationandreversaloftemporarydifferences": 1763000,
    "taxexpenseincomeatapplicabletaxrate": 8961000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 27187000,
    "taxeffectofrevenuesexemptfromtaxation2011": 30292000,
    "taxeffectofforeigntaxrates": 1249000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -5563000,
    "incometaxadvance": 9227000,
    "surplusinprivateliquidation": 9563000,
    "othertaxassets": 2397000,
    "incometaxwithholding": -2274000,
    "incometaxpayable": -2797000,
    "othertaxliabilities": -1062000,
    "unusedtaxcreditsforwhichnodeferredtaxassetrecognised": 4752000,
    "unusedtaxlossesandtaxcreditsforwhichnodeferredtaxassetrecognised": 4752000,
    "increasedecreasethroughnetexchangedifferencesgoodwill": 174000,
    "impairmentlossongoodwill": 838000,
    "annualdiscountratepercentage": 0.17500000000000002,
    "noofyearusedinprojectionofafixedannualgrowthrateperiod": 5,
    "descriptionofgrowthrateusedtoextrapolatecashflowprojections": 0.03,
    "salesgrowthrate": -0.035,
    "grossmargin": 0.27899999999999997,
    "expectedmarketsharepercentage": 0.18100000000000002,
    "amortisationintangibleassetsotherthangoodwill": 4933000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 2250000,
    "additionsfrominternaldevelopmentsintangibleassetotherthangoodwill": 8713000,
    "disposalsandretirementsintangibleassetsotherthangoodwill": 203000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -3200000,
    "increasedecreasethroughtransfersandotherchangesintangibleassetsotherthangoodwill": 596000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 23157000,
    "disposalspropertyplantandequipment": 2014000,
    "depreciationpropertyplantandequipment": 5656000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -4455000,
    "increasedecreasethroughtransfersandotherchangespropertyplantandequipment": 41000,
    "otherpropertyplantandequipment": 73965000,
    "additiontorightofuseasset": 10261000,
    "depreciationrightofuseassets": 6255000,
    "derecognitionofcontract": 470000,
    "increasedecreasethroughtransfersandotherchangesrightofuseassets": 309000,
    "increasedecreasethroughnetexchangedifferencesrightofuseassets": -4643000,
    "noncurrentleaseliabilities": 25139000,
    "currentleaseliabilities": 9053000,
    "leaseliabilities": 574000,
    "interestonleaseliabilities": 1033000,
    "expenserelatingtoleasesoflowvalueassetsforwhichrecognitionexemptionhasbeenused": 115000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 862000,
    "proportionofownershipinterestandvotingrightsinjointventure": 0.5,
    "netassetsofpromedicalsa": 3789000,
    "proportionofthecompanyownershipinterestinpromedicalsa": 1895000,
    "otheradjustment": -390000,
    "currentrawmaterialsandcurrentproductionsupplies": 42701000,
    "workinprogress": 7412000,
    "finishedgoodsandmerchandise": 41492000,
    "currentinventoriesintransit": 11531000,
    "currentgrossinventories": 103136000,
    "othershorttermprovisions": 6303000,
    "inventoriestotal": 96833000,
    "currenttradereceivables": 126456000,
    "otherreceivables": 15211000,
    "impairmentlossrecognisedinprofitorlosstradereceivables": 1297000,
    "syndicatedtermloan": -530000,
    "othertermloan": 32437000,
    "factoringobligations": 809000,
    "bankoverdraft": 80000,
    "seniornotes1": 115000000,
    "interestbearingliabilities": 285935000,
    "borrowingsoriginalcurrency": "USD",
    "borrowingsinterestratebasis": "8.50% (Fixed) (2021: 4.75%)",
    "borrowingsmaturity": 2031,
    "bankoverdraftsandcreditcards": 80000,
    "totalnotes": 115000000,
    "paymentcashflows": -130881000,
    "newliabilitiescontingentliabilitiesrecognisedinbusinesscombination": 179417000,
    "otherchanges": -15967000,
    "borrowingendingbalance": 285935000,
    "tradeandotherreceivable": -449000,
    "intangibleassetsandgoodwill": 5112000,
    "borrowingsandtradeandothercurrentpayables": 2648000,
    "provisionsandotherliabilities": 1780000,
    "others": -523000,
    "netdeferredtaxassets": -847000,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -1763000,
    "incometaxrelatingtocomponentsofothercomprehensiveincome": 107000,
    "increasedecreasethroughothersdeferredtaxliabilityasset": -188000,
    "tradeandotherpayablestotradesuppliers": 81477000,
    "tradecurrentaccountsotherpayables": 808000,
    "interestpayableotherpayable": 3307000,
    "withholdingsandpayrollcontributionsotherpayables": 2512000,
    "othersotherpayables": 2082000,
    "othercurrentpayables": 8709000,
    "otherprovisions": 138000,
    "increasedecreasethroughnetexchangedifferencescurrentprovisions": 9000,
    "additionalprovisions": 43000,
    "provisionused": 415000,
    "publicshares": 58955,
    "foundershares": 43000,
    "pipeshares": 100000,
    "totalnewsharesissued": 201955,
    "spacidentifiablenetassetatfairvalue": 131086000,
    "transactionscost": 30063000,
    "listingexpenses": 73917000,
    "sharescapitalissued": 202000,
    "sharespremiumtotal": 174738000,
    "statutoryreserve": 4892000,
    "workingcapitalreserve": 40851000,
    "increaseinworkingcapitalreserve": 2994000,
    "increasedecreaseinnumberofordinarysharesissued": 101110,
    "weightedaverageshares": 101110,
    "adjustedweightedaverageshares": 101110,
    "publicwarrantliability": 9200000,
    "privatewarrantliability": 1716000,
    "fairvalueremeasurementpublicwarrants": -6800000,
    "fairvalueremeasurementprivatewarrants": -5396000,
    "equityinterestsofacquirer": 926287000,
    "equityinterestsinholdcoissuedtospacshareholderspipeinvestors": 0.19,
    "equityinterestinholdcoofsellingshareholder": 0.81,
    "deemedcostsofsharesissued": 213584000,
    "identifiableassetsacquiredliabilitiesassumed": 131086000,
    "acquisitionrelatedcostsfortransactionrecognisedseparatelyfromacquisitionofassetsandassumptionofliabilitiesinbusinesscombination": 82498000,
    "dilutiveeffectsharesheldinescrow": 8581000,
    "acquisitionsfairvalue": 101859000,
    "gainsonchangeinfairvalueofderivatives": 61795000,
    "acquisitionsfairvalueend": 40064000,
    "financialassets": 175289000,
    "financialliabilities": 102799000,
    "borrowings": 285934000,
    "tradeandotherpayablestorelatedparties": 2914000,
    "totalfinancialliabilities": 379035000,
    "weightedaveragelossrates": 0.14070000000000002,
    "grosscarryingamount": 169352000,
    "impairmentlossallowance": 23834000,
    "totalhistoricaldataandadjusthistoricallossrates": 145518000,
    "monetaryassets": 1346000,
    "monetaryliabilities": -2814000,
    "additiontenpercentimpacttoprofitorlossbeforetax": 133000,
    "minustenpercentimpacttoprofitorlossbeforetax": -163000,
    "borrowingsnonderivativefinancialliabilities": 563000,
    "tradeandotherpayablesnonderivativefinancialliabilities": 90187000,
    "leaseliabilitiesnonderivativefinancialliabilities": 14274000,
    "amountsowedtorelatedpartiesnonderivativefinancialliabilities": 2914000,
    "totalnonderivativefinancialliabilities": 14274000,
    "revenuefromsaleofgoodsrelatedpartytransactions": 8038000,
    "revenuefromrenderingofservicesrelatedpartytransactions": 1034000,
    "purchasesofgoodsrelatedpartytransactions": 12367000,
    "tradeandotherreceivablesbyrelatedparties": 14028000,
    "loansowedbyrelatedparties": 215000,
    "provisions": 11769000,
    "amountsreceivablerelatedpartytransactions": 2474000,
    "tradeandotherpayabletorelatedparties": 2853000,
    "loansowedtorelatedparties": 61000,
    "amountspayablerelatedpartytransactions": 2914000,
    "loansowedfromrelatedparties": 215000,
    "interestaccruedloansowedtorelatedparties": 76000,
    "shorttermemployeebenefitsexpense": 2415000,
    "consultingfees": 3357000,
    "totalmanagementcompensationprofitlosss": 5772000,
    "annualgrossrevenue": 1235000000,
    "nonaffiliatesexceeds": 700000000,
    "nonconvertibledebtsecurities": 1000000000,
    "bridgeloans": 485000000,
    "aggregateprincipalamountpercentage": 0.0475,
    "pricesspecifiedinforwardagreementstopurchasefinancialassetsforcash": 1488204600,
    "currentliability": 139155000,
    "networkingcapitaldeficit": 70931000,
    "currentborrowingsrelatetotheloanbreach": 139155000,
    "tradeandotherpayablesrecognisedasofacquisitiondate": 90187000,
    "owedtorelatedparties": 2914000,
    "changesinotherprovisions": 138000,
    "otherliabilities": 11477000,
    "leasesofasset": 5000000,
    "customerstradereceivablepercentage": 0.5,
    "outofperiodinterestexpense": 268000,
    "reserveofremeasurementsofdefinedbenefitplans": 222000,
    "othercurrentnonfinancialliabilities": 2329000,
    "othernonfinancialliabilities": 185000,
    "costofsalesoutofperiodadjustments": 1639000,
    "salesandmarketingexpenses": 232000,
    "administrativeexpense": 643000,
    "costsofdefinedbenefitplans": 28494000,
    "administrativeexpenses": 41329000,
    "marketingandadvertisingexpense": 36304000,
    "proportionofownershipinterestinjointventure": 0.5,
    "votingrightspercentage": 0.5,
    "provisionpercentage": 0.5,
    "percentageofreasonablypossibledecreaseinunobservableinputliabilities": 0.1,
    "revenuefromrenderingofservices": 7098000,
    "revenueconcentrationpercentage": 0.1,
    "bankfees": 6076000,
    "interestexpenseonleaseliabilities": 1033000,
    "interestexpenseonbonds": 1601000,
    "taxrateeffectfromchangeintaxrate": 0.15,
    "corporatetaxrate": 0.35000000000000003,
    "impairmentloss": 6018000,
    "remainingcarryingamount": 2744000,
    "impairmentlossrecognisedinprofitorlosspropertyplantandequipment": 4689000,
    "unrecognizedimpairmentloss": 5723000,
    "sellinggeneralandadministrativeexpense": 1152000,
    "capitalcommitments": 2304000,
    "assetpurchaseagreementdescription": "Asof December 31, 2021 the Group acquired an 86,000 sq. ft. pharmaceutical production facility. The purchase price allocated to property,plant and equipment based on the estimated fair value of the assets acquired at the date of the asset acquisition was $1,487. Pleaserefer to Note 26.2. Asset acquisition - Pharmaceutical production facility.",
    "rightofuseassetsthatdonotmeetdefinitionofinvestmentproperty": 1373000,
    "distributionandadministrativeexpense": 4469000,
    "costofgoodssold": 1786000,
    "cashoutflowforleases": 6679000,
    "proportionofvotingrightsheldinjointventure": 0.5,
    "costofinventoriesrecognisedasexpenseduringperiod": 170351000,
    "inventoriesrecognizedasmarketingexpenses": 6659000,
    "writedowntonetrealizablevalue": 5717000,
    "discountprovisionamounts": 13443000,
    "collateralizedforfactoringtradereceivables": 2547000,
    "loaninstallmentterm": 5,
    "percentageofinterestrate": 0.053,
    "borrowingsinterestrate": 0.048,
    "financialcommitmentsofdescription": "●",
    "othercommitmentsofdescription": "●",
    "liabilityforunpaidclaimsandclaimsadjustmentexpensesincurredclaims": 115000000,
    "otherborrowings": 19000000,
    "descriptionofbtgcreditagreement": "●",
    "additionalprovisionsotherprovisions": 13566000,
    "grossleaseliabilities": 1501,
    "shareissuerelatedcost": 2142,
    "initialpurchasers": 1390,
    "attorneyscosts": 752,
    "descriptionoffinancialratios": "●",
    "otheradjustmentsfornoncashitems": 32358000,
    "additionstorightofuseassets": 12647000,
    "costamortization": 360000,
    "deferredtaxasset": 1663000,
    "taxeffectoftaxlosses": 1088000,
    "temporarydifferencesofdeferredtaxasset": 4752000,
    "laborandcivillitigation": 76000,
    "labourlitigations": 62000,
    "proposedsanctionamount": 1087000,
    "proposedtaxchargeamount": 348000,
    "numberofsharesauthorised": 800000000,
    "numberofsharesoutstanding": 2904146,
    "ordinarysharescent": "one",
    "numberofsharesissued": 112824184,
    "ordinarysharegrantvote": "one",
    "ordinarysharevoterighttodividend": "one",
    "stockissuedduringperiodsharestreasurystock": 4500000,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 4500000,
    "shareissued": 1250000,
    "dilutiveeffectofconvertibleinstrumentsonnumberofordinaryshares": 4500000,
    "deemedcostofinvestmentsforwhichdeemedcostispreviousgaapcarryingamount": 201955000,
    "totalaggregatepriceofshares": 202000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 11714612,
    "impairmentlossrecognisedinprofitorlossgoodwill": 106364000,
    "earningspersharesheldunderputoption": 903075,
    "privatewarrantsshares": 2875000,
    "warrantpersharedescription": "●",
    "perwarrant": 0.01,
    "exceedspershare": 18,
    "saleofwarrants": 6250000,
    "privateplacementwarrantpershare": 1,
    "generatinggrossproceeds": 6250000,
    "forfeitedsharesofprivateplacementwarrants": 2875000,
    "privatewarrantsinescrowshare": 2875000,
    "warrantpurchaseofordinarypershare": 1,
    "exercisepriceofoutstandingshareoptions2019": 11.5,
    "businesscombinationexpires": 5,
    "sponsorprivatewarrantshares": 1437500,
    "exceedsordinarypershares": 13,
    "expirationdate": "P5Y",
    "sponsorprivatewarrantsshares": 1437500,
    "descriptionofsharesinescrow": "10,464,612",
    "escrowmeasuredatfairvalue": 2138,
    "fairvalueoftheexhibitedfigures": 41780000,
    "concentrationofcreditriskpercentage": 0.1,
    "additionsofimpairmentlossallowance": 2673000,
    "impairmentlossesrelatedtorelatedparties": 195000,
    "percentageofincreaseanddecreases": 0.1,
    "changeinexchangeratespercentage": 0.1,
    "interestatavariablerate": 102799000,
    "interestatavailableratepercentage": 0.35950000000000004,
    "interestratespread": 0.01,
    "increasedecreaseinfairvaluemeasurementduetoreasonablypossibledecreaseinunobservableinputrecognisedinprofitorlossbeforetaxassets": 1028000,
    "profitbeforetaxpercentage": 0.01,
    "totalgrosstradereceivables": 0.05,
    "currentborrowingsrelatestotheloanbreach": 139155000,
    "debtrenegotiationsbalance": 19000000,
    "syndicatedbalance": 38626000,
    "outstandingobligationamount": 5719000,
    "descriptionofindicativefactsofindebtedness": "●",
    "descriptionofindicativefactsofindebtednessandleverageratioatcp": "●",
    "descriptionoftotalconsolidateddebtofthegroupandtheinterestcoverageratioandfinallytheindebtednessratio": "●",
    "interestexpensefromrelatedparties": 76000,
    "noncurrentreceivables": 18060,
    "relatedpartiesrepayableterm": "one year",
    "averageinterestrate": 0.06,
    "entityregistrantname": "Procaps Group, S.A.",
    "tradingsymbol": "PROCW",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 112824183,
    "amendmentflag": "false",
    "entitycentralindexkey": 1863362,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-38354",
    "entityincorporationstatecountrycode": "Luxembourg",
    "contactpersonnelname": "Ruben Minski",
    "entityaddressaddressline1": "9 rue de Bitbourg",
    "entityaddresspostalzipcode": "L-1273",
    "entityaddresscityortown": "Luxembourg",
    "entityaddresscountry": "Luxembourg",
    "cityareacode": 356,
    "localphonenumber": "7995-6138",
    "contactpersonnelemailaddress": "ir@procapsgroup.com",
    "security12btitle": "Warrants",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorlocation": "Bogotá, Colombia",
    "auditorname": "Deloitte & ToucheS.A.S",
    "auditorfirmid": 1183
  }
]